Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure
Clinical trial NCT04352205 · TERMINATED
Trial details
- NCT number
- NCT04352205
- Sponsor
- Emory University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-07
- Primary completion
- 2024-01-19
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.